We are live on ! Find out more
MGLN

Magellan Health Services, Inc.

Delisted

MGLN was delisted on the 3rd of January, 2022.

228 hedge funds and large institutions have $2.34B invested in Magellan Health Services, Inc. in 2018 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 80 increasing their positions, 88 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

9% less repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 88

5% less funds holding

Funds holding: 240228 (-12)

9% less capital invested

Capital invested by funds: $2.58B → $2.34B (-$239M)

31% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 36

69% less call options, than puts

Call options by funds: $1.3M | Put options by funds: $4.23M

Holders
228
Holders Change
-12
Holders Change %
-5%
% of All Funds
5.22%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
25
Increased
80
Reduced
88
Closed
36
Calls
$1.3M
Puts
$4.23M
Net Calls
-$2.92M
Net Calls Change
+$837K
Name Holding Trade Value Shares
Change
Change in
Stake
AIM
126
Assured Investment Management
New York
$1.05M +$641K +6,691 +158%
Wellington Management Group
127
Wellington Management Group
Massachusetts
$1.02M -$201K -2,100 -16%
SEC
128
Seven Eight Capital
New York
$1.02M +$1.02M +10,600 New
Parallax Volatility Advisers
129
Parallax Volatility Advisers
California
$988K +$987K +10,294 New
GC
130
Guggenheim Capital
Illinois
$914K -$1.42M -14,770 -61%
B
131
Bailard
California
$906K
Citigroup
132
Citigroup
New York
$814K -$3.76M -39,180 -82%
TRSOTSOK
133
Teachers Retirement System of the State of Kentucky
Kentucky
$812K
SOADOR
134
State of Alaska Department of Revenue
Alaska
$773K +$20.1K +210 +3%
Two Sigma Investments
135
Two Sigma Investments
New York
$768K -$681K -7,100 -47%
MLICM
136
Metropolitan Life Insurance Company (MetLife)
New York
$762K +$54.5K +569 +8%
LCM
137
Laurion Capital Management
New York
$757K -$853K -8,900 -53%
SGAM
138
Smith Group Asset Management
Texas
$719K -$1.83M -19,101 -72%
ARTA
139
A.R.T. Advisors
New York
$708K +$707K +7,380 New
SRAM
140
Stone Ridge Asset Management
New York
$685K +$16.4K +171 +2%
MSA
141
Mason Street Advisors
Wisconsin
$682K +$34.9K +364 +5%
CGH
142
Crossmark Global Holdings
Texas
$678K +$35.5K +370 +6%
GCP
143
GSA Capital Partners
United Kingdom
$663K +$95.6K +997 +17%
OA
144
Oak Associates
Ohio
$661K
UFF
145
USA Financial Formulas
Michigan
$607K -$959 -10 -0.2%
BCM
146
BlueCrest Capital Management
Jersey
$587K +$391K +4,078 +200%
American Century Companies
147
American Century Companies
Missouri
$574K -$26.8K -280 -4%
PIA
148
Piedmont Investment Advisors
North Carolina
$551K +$51.7K +539 +10%
FIM
149
Freedom Investment Management
Connecticut
$541K +$71.3K +744 +15%
AW
150
Alpha Windward
Massachusetts
$530K +$529K +5,520 New

MGLN Hedge Fund Activity: Q2 2018 in Review

228 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Magellan Health Services, Inc. (MGLN) for Q2 2018, worth a combined $2.34B — down 9.3% from $2.58B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of MGLN and 25 opened new positions — a net loss of 11 holders — while 88 trimmed existing stakes and 80 added.

The largest buyer was Fidelity Investments, adding an estimated $65.8M. The largest seller was OrbiMed, cutting an estimated $30M.

  • 228 institutional investors held Magellan Health Services, Inc. (MGLN) as of Q2 2018, down from 240 in Q1 2018.
  • Funds reported $2.34B of Magellan Health Services, Inc. stock for Q2 2018, down 9.3% quarter-over-quarter.
  • 25 funds opened new Magellan Health Services, Inc. positions in Q2 2018 and 36 closed out, a net change of -11 holders.
  • The largest Magellan Health Services, Inc. buyer in Q2 2018 was Fidelity Investments, an estimated $65.8M added.
  • The largest Magellan Health Services, Inc. seller in Q2 2018 was OrbiMed, an estimated $30M sold.

Based on aggregated 13F filings for Q2 2018.